Involvement of neutrophil hyporesponse and the role of toll-like receptors in human immunodeficiency virus 1 protection
Neutrophils contribute to pathogen clearance through pattern recognition receptors (PRRs) activation. However, the role of PRRs in neutrophils in both HIV-1-infected [HIV-1(+)] and HIV-1-exposed seronegative individuals (HESN) is unknown.
- Autores:
-
Hernández López, Juan Carlos
Giraldo, D. M.
Paul, S.
Urcuqui Inchima, S.
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2023
- Institución:
- Universidad Cooperativa de Colombia
- Repositorio:
- Repositorio UCC
- Idioma:
- OAI Identifier:
- oai:repository.ucc.edu.co:20.500.12494/49617
- Acceso en línea:
- https://doi.org/10.1371/journal.pone.0119844
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84925780426&doi=10.1371%2fjournal.pone.0119844&partnerID=40&md5=7cc442516e003008bd5634dd816c3eb4
https://hdl.handle.net/20.500.12494/49617
- Palabra clave:
- ADULT
ARTICLE
CASPASE RECRUITMENT DOMAIN PROTEIN 15
CASPASE RECRUITMENT DOMAIN PROTEIN 4
CLINICAL ARTICLE
CONTROLLED STUDY
CPG-B 2006
CYTOKINE PRODUCTION
DOWN REGULATION
FEMALE
GENE EXPRESSION REGULATION
HUMAN
HUMAN IMMUNODEFICIENCY VIRUS 1
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION
IL 18 GENE
IL 1BETA GENE
IL 6 G
IMMUNOLOGICAL ADJUVANT
INTERLEUKIN 18
INTERLEUKIN 1BETA
INTERLEUKIN 6
INTERLEUKIN DERIVATIVE
LIPOPEPTIDE
LIPOPOLYSACCHARIDE
LYMPHOTOXIN
MESSENGER RNA
OLIGODEOXYRIBONUCLEOTIDE
PAM2CSK4 LIPOPEPTIDE
PATTERN RECOGNITION RECEPTOR
REACTIVE OXYGEN METABOLITE
RETINOIC ACID INDUCIBLE PROTEIN I
TLR2 PROTEIN, HUMAN
TLR4 PROTEIN, HUMAN
TLR9 PROTEIN, HUMAN
TOLL LIKE RECEPTOR
TOLL LIKE RECEPTOR 2
TOLL LIKE RECEPTOR 4
TOLL LIKE RECEPTOR 9
TOLL LIKE RECEPTOR AGONIST
TRANSFORMING GROWTH FACTOR BETA
TUMOR NECROSIS FACTOR
TUMOR NECROSIS FACTOR ALPHA
- Rights
- openAccess
- License
- http://purl.org/coar/access_right/c_abf2
Summary: | Neutrophils contribute to pathogen clearance through pattern recognition receptors (PRRs) activation. However, the role of PRRs in neutrophils in both HIV-1-infected [HIV-1(+)] and HIV-1-exposed seronegative individuals (HESN) is unknown. |
---|